Call Now: +1 858 800 3101 Email: info@innopep.com
Overview | |
---|---|
Description | The epidermal growth factor receptor variant III (EGFRvIII) is a consistent tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms. As such it represents a truly tumor-specific target for antitumor immunotherapy. |
Sequence | {Leu}{Glu}{Glu}{Lys}{Lys}{Gly}{Asn}{Tyr}{Val}{Val}{Thr}{Asp}{His}{Cys} |
Sequence Shortening | LEEKKGNYVVTDHC |
Molecular Weight | 1634.82 |
Properties | |
Purity | > 95% |
Gmp Flag | 0 |
Storage | Store at -20°C. |
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.